Corticotropin-releasing factor receptor-dependent effects of repeated stress on tau phosphorylation, solubility, and aggregation

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 16, 2012, Pages 6277-6282

  Rissman, Robert A ^a   Staup, Michael A ^a   Lee, Allyson Roe ^a   Justice, Nicholas J ^b   Rice, Kenner C ^c   Vale, Wylie ^d   Sawchenko, Paul E ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^d SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

Electron microscopy; Neurofibrillary tangles; Pathology; Western blot

Indexed keywords

CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; TAU PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; HIPPOCAMPUS; IMMUNOGOLD LABELING; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SOLUBILITY; STRESS; TRANSGENIC MOUSE; ULTRASTRUCTURE ANALYSIS AND ELECTRON MICROSCOPY; WILD TYPE;

ANIMALS; BLOTTING, WESTERN; DENTATE GYRUS; DETERGENTS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GREEN FLUORESCENT PROTEINS; HIPPOCAMPUS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MICROSCOPY, IMMUNOELECTRON; NEURONS; PHOSPHORYLATION; PYRIMIDINES; PYRROLES; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SOLUBILITY; STRESS, PSYCHOLOGICAL; TAU PROTEINS;

EID: 84859949970     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1203140109     Document Type: Article

References (54)

1. Braak H, Braak E (1991) Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 82:239-259.
2. Alonso AC, Grundke-Iqbal I, Iqbal K (1996) Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. Nat Med 2:783-787. (Pubitemid 26225094)
3. Stamer K, Vogel R, Thies E, Mandelkow E, Mandelkow EM (2002) Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J Cell Biol 156:1051-1063. (Pubitemid 34839854)
4. HuttonM, et al. (1998) Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393:702-705.
5. Spillantini MG, et al. (1998) Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci USA 95:7737-7741. (Pubitemid 28293323)
6. Wilson RS, et al. (2003) Proneness to psychological distress is associated with risk of Alzheimer's disease. Neurology 61:1479-1485. (Pubitemid 37505565)
7. Wilson RS, et al. (2005) Distress proneness and cognitive decline in a population of older persons. Psychoneuroendocrinology 30:11-17. (Pubitemid 39195040)
8. Dong H, et al. (2004) Modulation of hippocampal cell proliferation, memory, and amyloid plaque deposition in APPsw (Tg2576) mutant mice by isolation stress. Neuroscience 127:601-609. (Pubitemid 38993164)
9. Kang JE, Cirrito JR, Dong H, Csernansky JG, Holtzman DM (2007) Acute stress increases interstitial fluid amyloid-β via corticotropin-releasing factor and neuronal activity. Proc Natl Acad Sci USA 104:10673-10678. (Pubitemid 47185723)
10. Rissman RA (2009) Stress-induced tau phosphorylation: Functional neuroplasticity or neuronal vulnerability? J Alzheimers Dis 18:453-457.
11. Yan J, et al. (2010) Chronic restraint stress alters the expression and distribution of phosphorylated tau and MAP2 in cortex and hippocampus of rat brain. Brain Res 1347:132-141.
12. Sotiropoulos I, et al. (2011) Stress acts cumulatively to precipitate Alzheimer's diseaselike tau pathology and cognitive deficits. J Neurosci 31:7840-7847.
13. Roe AD, Staup MA, Serrats J, Sawchenko PE, Rissman RA (2011) Lipopolysaccharideinduced tau phosphorylation and kinase activity-Modulation, but not mediation, by corticotropin-releasing factor receptors. Eur J Neurosci 34:448-456.
14. Zhang LF, et al. (2011) Increased hippocampal tau phosphorylation and axonal mitochondrial transport in a mouse model of chronic stress. Int J Neuropsychopharmacol 15:337-348.
15. Carroll JC, et al. (2011) Chronic stress exacerbates tau pathology, neurodegeneration, and cognitive performance through a corticotropin-releasing factor receptor-dependent mechanism in a transgenic mouse model of tauopathy. J Neurosci 31:14436-14449.
16. Cui B, Wu M, She X, Liu H (2012) Impulse noise exposure in rats causes cognitive deficits and changes in hippocampal neurotransmitter signaling and tau phosphorylation. Brain Res 1427:35-43.
17. Rissman RA, Lee KF, Vale W, Sawchenko PE (2007) Corticotropin-releasing factor receptors differentially regulate stress-induced tau phosphorylation. J Neurosci 27:6552-6562. (Pubitemid 46920385)
18. Webster EL, et al. (1996) In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: Suppression of pituitary ACTH release and peripheral inflammation. Endocrinology 137:5747-5750. (Pubitemid 26423152)
19. Cottone P, et al. (2009) CRF system recruitment mediates dark side of compulsive eating. Proc Natl Acad Sci USA 106:20016-20020.
20. Justice NJ, Yuan ZF, Sawchenko PE, ValeW(2008) Type 1 corticotropin-releasing factor receptor expression reported in BAC transgenic mice: Implications for reconciling ligand-receptor mismatch in the central CRF system. J Comp Neurol 511:479-496.
21. Greenberg SG, Davies P (1990) A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. Proc Natl Acad Sci USA 87:5827-5831.
22. Iqbal K, Zaidi T, Thompson CH, Merz PA, Wisniewski HM (1984) Alzheimer paired helical filaments: Bulk isolation, solubility, and protein composition. Acta Neuropathol 62:167-177. (Pubitemid 14178592)
23. Rubenstein R, et al. (1986) Paired helical filaments associated with Alzheimer disease are readily soluble structures. Brain Res 372:80-88. (Pubitemid 16024100)
24. Sawchenko PE, et al. (1996) The paraventricular nucleus of the hypothalamus and the functional neuroanatomy of visceromotor responses to stress. Prog Brain Res 107: 201-222. (Pubitemid 26401667)
25. Braak E, Braak H, Mandelkow EM (1994) A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol 87:554-567. (Pubitemid 24158408)
26. Hirata-Fukae C, et al. (2009) Levels of soluble and insoluble tau reflect overall status of tau phosphorylation in vivo. Neurosci Lett 450:51-55.
27. Oddo S, Billings L, Kesslak JP, Cribbs DH, LaFerla FM (2004) Aβ immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron 43:321-332. (Pubitemid 39061125)
28. Van Pett K, et al. (2000) Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol 428:191-212.
29. Okawa Y, Ishiguro K, Fujita SC (2003) Stress-induced hyperphosphorylation of tau in the mouse brain. FEBS Lett 535:183-189. (Pubitemid 36126378)
30. Filipcik P, et al. (2012) Tau protein phosphorylation in diverse brain areas of normal and CRH-deficient mice: Up-regulation by stress. Cell Mol Neurobiol, 10.1007/s10571-011-9788-9.
31. Bale TL, Vale WW (2004) CRF and CRF receptors: Role in stress responsivity and other behaviors. Annu Rev Pharmacol Toxicol 44:525-557. (Pubitemid 38263852)
32. Weaver CL, Espinoza M, Kress Y, Davies P (2000) Conformational change as one of the earliest alterations of tau in Alzheimer's disease. Neurobiol Aging 21:719-727.
33. Jeganathan S, et al. (2008) Proline-directed pseudo-phosphorylation at AT8 and PHF1 epitopes induces a compaction of the paperclip folding of Tau and generates a pathological (MC-1) conformation. J Biol Chem 283:32066-32076.
34. King ME, Gamblin TC, Kuret J, Binder LI (2000) Differential assembly of human tau isoforms in the presence of arachidonic acid. J Neurochem 74:1749-1757. (Pubitemid 30163998)
35. Mailliot C, et al. (1998) Phosphorylation of specific sets of tau isoforms reflects different neurofibrillary degeneration processes. FEBS Lett 433:201-204. (Pubitemid 128369961)
36. Rohn TT, et al. (2002) Caspase-9 activation and caspase cleavage of tau in the Alzheimer's disease brain. Neurobiol Dis 11:341-354. (Pubitemid 36135697)
37. Zilka N, et al. (2006) Truncated tau from sporadic Alzheimer's disease suffices to drive neurofibrillary degeneration in vivo. FEBS Lett 580:3582-3588. (Pubitemid 43902790)
38. Berger Z, et al. (2007) Accumulation of pathological tau species and memory loss in a conditional model of tauopathy. J Neurosci 27:3650-3662. (Pubitemid 46557687)
39. Maeda S, et al. (2006) Increased levels of granular tau oligomers: An early sign of brain aging and Alzheimer's disease. Neurosci Res 54:197-201. (Pubitemid 43276078)
40. Maeda S, et al. (2007) Granular tau oligomers as intermediates of tau filaments. Biochemistry 46:3856-3861. (Pubitemid 46493485)
41. Sahara N, et al. (2007) Assembly of two distinct dimers and higher-order oligomers from full-length tau. Eur J Neurosci 25:3020-3029. (Pubitemid 46888808)
42. Park KH, Hallows JL, Chakrabarty P, Davies P, Vincent I (2007) Conditional neuronal simian virus 40 T antigen expression induces Alzheimer-like tau and amyloid pathology in mice. J Neurosci 27:2969-2978. (Pubitemid 46438995)
43. Sapolsky RM, Krey LC, McEwen BS (1985) Prolonged glucocorticoid exposure reduces hippocampal neuron number: Implications for aging. J Neurosci 5:1222-1227. (Pubitemid 15098432)
44. Sapolsky RM, Krey LC, McEwen BS (1986) The neuroendocrinology of stress and aging: The glucocorticoid cascade hypothesis. Endocr Rev 7:284-301.
45. Ballatore C, Lee VM, Trojanowski JQ (2007) Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat Rev Neurosci 8:663-672. (Pubitemid 47283144)
46. Kehne JH (2007) The CRF1 receptor, a novel target for the treatment of depression, anxiety, and stress-related disorders. CNS Neurol Disord Drug Targets 6:163-182.
47. Martinez V, Taché Y (2006) CRF1 receptors as a therapeutic target for irritable bowel syndrome. Curr Pharm Des 12:4071-4088. (Pubitemid 44669761)
48. Smith GW, et al. (1998) Corticotropin-releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 20:1093-1102. (Pubitemid 28293127)
49. Bale TL, et al. (2000) Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat Genet 24:410-414. (Pubitemid 30187443)
50. Heintz N (2001) BAC to the future: The use of bac transgenic mice for neuroscience research. Nat Rev Neurosci 2:861-870.
51. Pernar L, Curtis AL, Vale WW, Rivier JE, Valentino RJ (2004) Selective activation of corticotropin-releasing factor-2 receptors on neurochemically identified neurons in the rat dorsal raphe nucleus reveals dual actions. J Neurosci 24:1305-1311. (Pubitemid 38222980)
52. Planel E, et al. (2007) Anesthesia leads to tau hyperphosphorylation through inhibition of phosphatase activity by hypothermia. J Neurosci 27:3090-3097. (Pubitemid 46474135)
53. Higuchi M, et al. (2002) Transgenic mouse model of tauopathies with glial pathology and nervous system degeneration. Neuron 35:433-446. (Pubitemid 34879944)
54. Kraemer BC, et al. (2003) Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy. Proc Natl Acad Sci USA 100:9980-9985. (Pubitemid 37087054)